Case Report
Published on 09 Feb 2023
Case report: The diagnostic challenge of primary cardiac intimal sarcoma
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1089636
- 3,282 views
- 6 citations
Type at least 3 characters
247 articles
Original Research
Published on 08 Feb 2023
Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the “forgotten pulmonic valve”
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1071138
- 5,245 views
- 4 citations
Case Report
Published on 08 Feb 2023
Case report: Persistent ST-segment elevation due to cardiac metastasis from lung cancer
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1001527
- 2,332 views
- 4 citations
Original Research
Published on 07 Feb 2023
Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib, or nilotinib: A cohort study using data from a large multinational collaborative network
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.888366
- 5,551 views
- 1 citation
Original Research
Published on 07 Feb 2023
In-hospital and one-year outcomes in cancer patients receiving percutaneous coronary intervention for acute myocardial infarction: A real-world study
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1005473
- 2,470 views
Editorial
Published on 01 Feb 2023
Editorial: HF2Cancer: Exploring bidirectional interaction between cardiovascular diseases and cancer
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1145780
- 1,110 views
- 1 citation
Original Research
Published on 25 Jan 2023
Higher risk of cardiovascular mortality than cancer mortality among long-term cancer survivors
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1014400
- 5,246 views
- 27 citations
Original Research
Published on 24 Jan 2023
Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1073804
- 1,783 views
- 4 citations
Original Research
Published on 23 Jan 2023
Incidence of adverse cardiovascular events associated with immune checkpoint inhibitors and risk factors for left ventricular dysfunction: A single-center prospective clinical study
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1052699
- 3,085 views
- 12 citations
Correction
Published on 19 Jan 2023
Corrigendum: Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1129873
- 1,266 views
- 5 citations
Original Research
Published on 19 Jan 2023
Risk factors from Framingham risk score for anthracyclines cardiotoxicity in breast cancer: A systematic review and meta-analysis
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1101585
- 3,448 views
- 6 citations
Original Research
Published on 12 Jan 2023
Association between radiotherapy and risk of death from cardiovascular diseases in lung and bronchus cancer
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1068957
- 2,838 views
- 5 citations
Original Research
Published on 12 Jan 2023
Bioprosthetic valve monitoring in patients with carcinoid heart disease
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1072890
- 2,781 views
- 3 citations
Original Research
Published on 12 Jan 2023
Traditional risk factors and cancer-related factors associated with cardiovascular disease risk in head and neck cancer patients
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1024846
- 3,265 views
- 9 citations
Original Research
Published on 11 Jan 2023
Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.996809
- 7,071 views
- 5 citations
Original Research
Published on 06 Jan 2023
Ticagrelor reduces doxorubicin-induced pyroptosis of rat cardiomyocytes by targeting GSK-3β/caspase-1
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1090601
- 3,491 views
- 6 citations